An Horizon Europe-funded project aiming to optimise Therapeutic Epigenetic Enhancement of the Innate Immunity to Effectively Combat Antimicrobial Resistance
🧪 IN-ARMOR reaches a new milestone in nanocarrier development!
As part of WP3, led by @cinbio_uvigo , the project has successfully completed the optimisation and comprehensive characterisation of its mesoporous silica nanoparticle (MSNP)-based nanocarriers.
#EUFunded#HaDEA#AMR
🚀 This achievement strengthens the integration of nanotechnology, drug development and biological validation within the IN-ARMOR pipeline, supporting the progression of selected candidates towards preclinical evaluation.
#HostDirectedTherapy#Nanomedicine#DrugDelivery
🧬 Why is this a major step?
By reinforcing the host’s innate immune system rather than directly targeting bacteria, we aim to tackle antimicrobial resistance (#AMR) without contributing to drug resistance.
Discover more🌐 https://t.co/yjyN25bjj6
#EUfunded#HaDEA#DrugDevelopment
Safety first in #INARMOR research!
As part of WP4 (led by @Leitat ), our team completed the in vivo tolerability assessment and established Maximum Tolerated Dose (#MTD) profiles for our therapeutic candidates.
Crucial groundwork before evaluating efficacy in disease models! 🧵👇
🧪 Led by #LEITAT, with the key collaboration of #UniversityofIceland and WP2 partners, the team assessed key ADME-related properties, Caco-2 permeability and potential mechanisms of action.
🚀 Another step towards preclinical validation and innovative approaches to tackle #AMR.
New milestone achieved!
The consortium has completed the advanced characterisation of its selected lead compounds for host-directed therapies (HDTs) against antimicrobial resistance.
🔗 https://t.co/yjyN25bjj6
#EUFunded#HaDEA#INARMOR#HorizonEurope#HostDirectedTherapy
👏 Thank you to everyone who made these two days so productive.
🛡️🔬 Together, we continue working towards innovative approaches to tackle antimicrobial resistance (AMR).
#HaDEA#HorizonEurope#AMR#AntimicrobialResistance#HealthResearch
🌐 https://t.co/T7i66nHPu9
Two days in Madrid, one shared roadmap for the final phase of #INARMOR!
Our 4th Consortium Meeting brought together partners from across Europe to take stock of progress, discuss the path towards exploitation and impact, and align our priorities for the months ahead.
#EUFunded
🏥 We also had the opportunity to connect our research with the clinical environment during a visit to the Microbiology Department at Hospital Universitario Ramón y Cajal, hosted by #SERMAS and @microRyC.
🚀 Next stop: the final phase of IN-ARMOR — and the IN-ARMOR Final Expo!
🧵 Day 1 of the 4th #INARMOR Consortium Meeting in Madrid is a wrap!
Today, our 16 Horizon Europe partners came together to review key scientific and development milestones in the fight against antimicrobial resistance (#AMR).
#EUFunded#HaDEA
🔬 Plenary session: Updates spanning molecule synthesis and innate immunity to nanomedicine and regulatory activities across WP1–WP5.
💡 Technical workshops: Focused discussions on the experimental strategy and the selection of lead compounds for further development.
🚨 IN-ARMOR partners meet in Madrid! 🇪🇺
On 16–17 September, we hold our 4th Consortium Meeting & 14th Management Board Meeting, hosted by @SaludMadrid.
🤝 2 days to review progress, strengthen collaboration and plan the next steps in the fight against #AMR.
#EUFunded#HaDEA
✅ 2nd Periodic Review completed!
Grateful to our Project Officer & external reviewers for their rigorous evaluation and guidance. Huge thanks to all partners for their dedication in advancing our fight against #AMR 🦠🧬
Let’s go for the final stage! 💪
#EUFunded#HaDEA
Grateful for the experiences! Huge thanks to @uniovi_info for giving us the opportunity to share our work. Thanks for having us! 🚀✨
Learn more about TUAI here: https://t.co/HlfFpEWzsM
#ExplainableAI
We’ve presented #INARMOR 's AI-driven approach to antimicrobial resistance to the #TUAI Spring School, a #MSCA doctoral training network focused on explainable, transparent, and trustworthy AI.
That's how science moves forward.
🔗 https://t.co/yjyN25bjj6
#EUFunded#HaDEA#AMR